Celebrating 25 Years of Scoop
Licence needed for work use Learn More
 

Cartherics - Latest News [Page 1]

Cartherics Raises Over $15 Million In Oversubscribed Private Financing Round To Advance Cell Therapy Programs

Tuesday, 1 October 2024, 5:35 pm | Cartherics

This funding will support the initiation of the clinical trial for CTH-401, the Company’s lead cell therapy product, aimed at treating ovarian cancer, as well as broadening its pipeline to include other disease indications. More >>

Cartherics Enters Agreements With Uniquest, UQ & USYD For Advancing Innovative Cardiac Cellular Therapy

Thursday, 25 July 2024, 2:03 pm | Cartherics

In parallel, Cartherics, The University of Queensland (“UQ”) and The University of Sydney have entered into a related Material Transfer Agreement (MTA). More >>

Cartherics Secures Australian Patent For Innovative Cancer Cell Therapy

Wednesday, 12 June 2024, 6:29 pm | Cartherics

This patent enhances Cartherics’ expanding intellectual property portfolio and covers aspects of the Company’s chimeric antigen receptor (CAR) technology, particularly in relation to its CAR directed against the tumour-associated antigen, TAG-72. More >>

Cartherics Enters Into Collaborative Research Agreement With TiCARos

Wednesday, 3 April 2024, 7:56 am | Cartherics

Melbourne, Australia, 2 April 2024 – Cartherics Pty Ltd (“Cartherics”), a biotechnology company developing immune cell therapies for the treatment of cancer, is pleased to announce that it has entered a collaborative research agreement with ... More >>

Positive Pre-IND Meeting With US FDA For New Ovarian Cancer Cell Therapy

Thursday, 1 February 2024, 6:54 pm | Cartherics

Melbourne, Australia, 1 February 2024 – Cartherics Pty Ltd (“Cartherics” or “Company”), a biotechnology company developing immune cell therapies for the treatment of cancer, is pleased to announce that it has successfully completed a ... More >>

 
 
 
 
 

LATEST HEADLINES

  • PARLIAMENT
  • POLITICS
  • REGIONAL
 

Join Our Free Newsletter

Subscribe to Scoop’s 'The Catch Up' our free weekly newsletter sent to your inbox every Monday with stories from across our network.